| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Powerful Business & Technology Delivery
Franklin Law Firm, Llc is a Aiken, SC-based company in the Software & Internet sector.
Cogent Communications is a Augusta, GA-based company in the Software and Internet sector.
Established in 2011 in Germany, Pricefx AG is a provider of full suite price management and CPQ SaaS solutions. Our suite is based on the latest in native cloud architecture and offers flexible support for the entire price management closed loop cycle which includes pricing strategy, controlling, setting and realization. Our solution is suitable for B2B and B2C clients and is able to serve a wide array of industries. The platform is also designed to meet the specific pricing challenges of commercial organizations of any size or geographical location. Pricefx`s vision is to become the leading SaaS pricing solution provider by offering an easily implemented and flexible tool that is inexpensive, risk-free and fully comprehensive. Our business model is based entirely on the satisfaction and loyalty of our customers. If we do our job, they stay, and more importantly, they tell others about us.